137 related articles for article (PubMed ID: 17879516)
21. Lessons learned from the COURAGE trial: generalizability, limitations, and implications.
Franklin BA
Prev Cardiol; 2007; 10(3):117-20. PubMed ID: 17617772
[No Abstract] [Full Text] [Related]
22. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
[TBL] [Abstract][Full Text] [Related]
23. [Acute coronary syndrome: technological improvements in diagnostics and therapy].
Verheugt FW
Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2241-6. PubMed ID: 10578422
[TBL] [Abstract][Full Text] [Related]
24. [Acute coronary syndromes without ST-elevation -- treatment].
Weber M; Hamm C
Dtsch Med Wochenschr; 2003 Feb; 128(6):273-6. PubMed ID: 12571797
[No Abstract] [Full Text] [Related]
25. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA.
Brown DL
Cardiovasc Drugs Ther; 2022 Oct; 36(5):1039-1045. PubMed ID: 34767134
[TBL] [Abstract][Full Text] [Related]
26. The ten most commonly asked questions about intracoronary stents.
Cannan CR; Holmes DR
Cardiol Rev; 2001; 9(1):5-9. PubMed ID: 11174909
[No Abstract] [Full Text] [Related]
27. A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass.
Borkon AM; Muehlebach GF; House J; Marso SP; Spertus JA
Ann Thorac Surg; 2002 Nov; 74(5):1526-30; discussion 1530. PubMed ID: 12440603
[TBL] [Abstract][Full Text] [Related]
28. Directional coronary atherectomy for lesions of the proximal left anterior descending artery: initial clinical results, complications and histopathological findings.
Sankardas MA; McEniery P; Aroney C; Holt G; Cameron J; Garrahy P; Dare A; Bett N
Aust N Z J Med; 1995 Dec; 25(6):676-80. PubMed ID: 8770330
[TBL] [Abstract][Full Text] [Related]
29. To excel or to confirm? That is the question.
Dangas G
Catheter Cardiovasc Interv; 2011 Jun; 77(7):944. PubMed ID: 21598346
[No Abstract] [Full Text] [Related]
30. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
[TBL] [Abstract][Full Text] [Related]
32. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).
Bittner V; Hardison R; Kelsey SF; Weiner BH; Jacobs AK; Sopko G;
Circulation; 2002 Nov; 106(20):2537-42. PubMed ID: 12427648
[TBL] [Abstract][Full Text] [Related]
33. Indications for coronary bypass surgery, 1982. Controlled trials scientifically and ethically optimum.
Spodick DH
Adv Cardiol; 1982; 31():45-50. PubMed ID: 6983822
[No Abstract] [Full Text] [Related]
34. Percutaneous coronary intervention for patients with prior bypass surgery: therapy in evolution.
Bhatt DL; Topol EJ
Am J Med; 2000 Feb; 108(2):176-7. PubMed ID: 11126314
[No Abstract] [Full Text] [Related]
35. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
Aziz O; Rao C; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
BMJ; 2007 Mar; 334(7594):617. PubMed ID: 17337458
[TBL] [Abstract][Full Text] [Related]
36. [Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical therapy].
Nishigaki K
Nihon Rinsho; 2011 Feb; 69(2):253-8. PubMed ID: 21387672
[TBL] [Abstract][Full Text] [Related]
37. Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials.
Solomon AJ; Gersh BJ
Ann Intern Med; 1998 Feb; 128(3):216-23. PubMed ID: 9454530
[TBL] [Abstract][Full Text] [Related]
38. Residual high-grade angina after enhanced external counterpulsation therapy.
McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of saphenous vein bypass vs. native coronary artery balloon angioplasty: technical differences and angiographic response.
Kimball BP; Bui S
Cathet Cardiovasc Diagn; 1995 Apr; 34(4):293-9; discussion 300. PubMed ID: 7621538
[TBL] [Abstract][Full Text] [Related]
40. Left anterior descending coronary artery revascularization patient-tailored therapy?
Abbate A; Vetrovec GW
JACC Cardiovasc Interv; 2008 Oct; 1(5):492-3. PubMed ID: 19463350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
